F&V Capital Management LLC increased its holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 200.0% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 6,183 shares of the financial services provider’s stock after purchasing an additional 4,122 shares during the period. F&V Capital Management LLC’s holdings in iShares NASDAQ Biotechnology Index were worth $660,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Crestwood Advisors Group LLC increased its holdings in iShares NASDAQ Biotechnology Index by 1.6% in the 3rd quarter. Crestwood Advisors Group LLC now owns 69,893 shares of the financial services provider’s stock worth $23,316,000 after buying an additional 1,107 shares in the last quarter. Atlantic Trust Group LLC increased its holdings in iShares NASDAQ Biotechnology Index by 12.4% in the 3rd quarter. Atlantic Trust Group LLC now owns 20,642 shares of the financial services provider’s stock worth $6,887,000 after buying an additional 2,280 shares in the last quarter. Quantitative Investment Management LLC bought a new stake in iShares NASDAQ Biotechnology Index in the 2nd quarter worth about $103,504,000. Archford Capital Strategies LLC increased its holdings in iShares NASDAQ Biotechnology Index by 1,393.5% in the 2nd quarter. Archford Capital Strategies LLC now owns 64,087 shares of the financial services provider’s stock worth $1,085,000 after buying an additional 59,796 shares in the last quarter. Finally, Paradigm Financial Advisors LLC increased its holdings in iShares NASDAQ Biotechnology Index by 11.7% in the 2nd quarter. Paradigm Financial Advisors LLC now owns 7,315 shares of the financial services provider’s stock worth $2,268,000 after buying an additional 766 shares in the last quarter. Institutional investors own 21.10% of the company’s stock.

Shares of iShares NASDAQ Biotechnology Index (IBB) opened at $110.41 on Wednesday. iShares NASDAQ Biotechnology Index has a twelve month low of $88.96 and a twelve month high of $114.17. The company has a market capitalization of $10,310.00, a PE ratio of 3.65 and a beta of 1.38.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 28th. Investors of record on Friday, December 22nd were issued a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 0.45%. This is an increase from iShares NASDAQ Biotechnology Index’s previous quarterly dividend of $0.04. The ex-dividend date of this dividend was Thursday, December 21st. iShares NASDAQ Biotechnology Index’s dividend payout ratio (DPR) is presently 2.38%.

TRADEMARK VIOLATION NOTICE: “F&V Capital Management LLC Has $660,000 Stake in iShares NASDAQ Biotechnology Index (IBB)” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.dailypolitical.com/2018/01/10/fv-capital-management-llc-has-660000-stake-in-ishares-nasdaq-biotechnology-index-ibb.html.

iShares NASDAQ Biotechnology Index Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.